Recently, estrogen receptor alpha 36 (ERα36), a newly discovered estrogen receptor α-subtype in liver, which is prominently upregulated only in hepatoma cells but not in normal hepatocytes, has been recognized as a potential EGCG target in HCC. The gene discussed is ESR1; the disease is hepatocellular carcinoma.